TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
EWTX

Edgewise Therapeutics Inc

Healthcare · Biotechnology

41.40$ +2.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EWTX
Line item 2019 2020 2021 2022 2023 2024 2025
– +434.4% +117.5% +28.7% -7.4% +43.2% +13.5%
– +439.2% +118.9% +25.8% -8.4% +45.4% +14.3%
– +343.6% -85.2% +41.3% +291.5% -51.6% +46.8%
– +445.8% +117.5% +25.3% -9.5% +47.7% +12.7%
– – – -54.2% – – –
– +3.6% +76.7% +835.6% – – –
– +297.5% -93.4% +87.9% +4.0% +30.2% +9.9%
– +283.6% +142.3% +57.6% +1.1% +42.3% +14.7%
– – – – +61.2% +1.6% +1.8%
– +136.9% +143.2% +58.9% -34.1% +38.6% +7.7%
– – – +26.4% -8.0% +44.0% +13.7%
– – – – – – –
– +0.0% +0.6% +8.3% +18.9% +45.0% +11.4%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?